Abstract:Chronic thromboembolic pulmonary hypertension (CTEPH) is part of group 4 of the pulmonary hypertension (PH) classification and generally affects more than a third of patients referred to PH centers. It is a three-compartment disease involving proximal (lobar-to-segmental) and distal (subsegmental) pulmonary arteries that are obstructed by persistent fibrothrombotic material, and precapillary pulmonary arteries that can be affected as in pulmonary arterial hypertension. It is a rare complication of pulmonary embolism (PE), with an incidence of around 3% in PE survivors. The observed incidence of CTEPH in the general population is around six cases per million but could be three times higher than this, as estimated from PE incidence. However, a previous venous thromboembolic episode is not always documented. With advances in multimodality imaging and therapeutic management, survival for CTEPH has improved for both operable and inoperable patients. Advanced imaging with pulmonary angiography helps distinguish proximal from distal obstructive disease. However, right heart catheterization is of utmost importance to establish the diagnosis and hemodynamic severity of PH. The therapeutic strategy relies on a stepwise approach, starting with an operability assessment. Pulmonary endarterectomy (PEA), also known as pulmonary thromboendarterectomy, is the first-line treatment for operable patients. Growing experience and advances in surgical technique have enabled expansion of the distal limits of PEA and significant improvements in perioperative and mid- to long-term mortality. In patients who are inoperable or who have persistent/recurrent PH after PEA, medical therapy and/or balloon pulmonary angioplasty (BPA) are effective treatment options with favorable outcomes that are increasingly used. All treatment decisions should be made with a multidisciplinary team that includes a PEA surgeon, a BPA expert, and a chest radiologist.

Status and progress of surgical treatment of chronic thromboembolic pulmonary hypertension

Chronic thromboembolic pulmonary disease

Recent Progress in Research on the Pathogenesis of Pulmonary Thromboembolism: an Old Story with New Perspectives

Autologous Endothelial Progenitor Cells Transplantation for the Therapy of Primary Pulmonary Hypertension

Pulmonary Thromboendarterectomy: The Potentially Curative Treatment of Choice for Chronic Thromboembolic Pulmonary Hypertension

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: State of the art

Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: preliminary exploration in China.

Right ventricle remodeling in chronic thromboembolic pulmonary hypertension

The long-term outcome of chronic thromboembolic pulmonary hypertension: Pulmonary endarterectomy and balloon pulmonary angioplasty

Current surgical management of chronic thromboembolic pulmonary disease

The management pattern and outcomes of chronic thromboembolic pulmonary hypertension: rationale and design for a Chinese real-world study

Surgical Treatment on Congenital Heart Disease with Severe Pulmonary Hypertension

Pulmonary endarterectomy (PEA): the treatment for chronic thromboembolic pulmonary hypertension (CTEPH)

[From acute pulmonary embolism to chronic thromboembolic pulmonary hypertension: Pathobiology and pathophysiology]

[Progress in Surgical Treatment of Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava].

Improvements in Hemodynamics and Right Heart Remodeling Following Balloon Pulmonary Angioplasty Treatment in Patients with Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Study

Chronic thromboembolic pulmonary hypertension: A comprehensive review of pathogenesis, diagnosis, and treatment strategies

Clinical Analysis of 106 Cases Pulmonary Embolism

Advances in the targeted therapy for pulmonary arterial hypertension

Clinical outcome of lung transplantation for chronic thromboembolic pulmonary hypertension

Advance in Medical Therapies for Chronic Thromboembolic Pulmonary Hypertension